[
    [
        {
            "time": "",
            "original_text": "速读社丨上海医药子公司孙公司对簿公堂 美国砸下1.9亿美元推动基因编辑疗法进程",
            "features": {
                "keywords": [
                    "上海医药",
                    "子公司",
                    "法律纠纷",
                    "美国",
                    "基因编辑",
                    "疗法",
                    "1.9亿美元"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "速读社丨上海医药子公司孙公司对簿公堂 美国砸下1.9亿美元推动基因编辑疗法进程",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]